Alani H, Tamimi A, Tamimi N. Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs. World J Nephrol 2014; 3(4): 156-168 [PMID: 25374809 DOI: 10.5527/wjn.v3.i4.156]
Corresponding Author of This Article
Dr. Nihad Tamimi, MBBS, MSc, FRCP, Pfizer Worldwide Research and Development, Pfizer Inc, 610 Main Street, Cambridge, MA 02139, United States. nihad.tamimi@pfizer.com
Research Domain of This Article
Urology & Nephrology
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/